Sign Up Today and Learn More About Cellworks Stock

Invest in or calculate the value of your shares in Cellworks or other pre-IPO companies through EquityZen's platform.

Get Started

Cellworks Stock

Cellworks is a life sciences technology company involved in drug and bio-marker discovery and researches in therapeutic areas.

About Cellworks Stock

Founded

2005

Headquarters

San Jose, CA, US

Total Funding

17.5M

Cellworks Group, Inc. operates as a life sciences technology company. The company provides iC-PHYS, a technology platform that enables drug and bio-marker discovery and research in focused therapeutic areas. The company provides disease focused drug discovery and research solutions in the areas of oncology, such as integrated tumor cell and endothelial cell with stromal inputs; inflammation diseases, such as macrophage, neutrophil, osteoclast, and T-cell; type-2 diabetes; infectious diseases; skin pigmentation and ageing; and neurodegenerative. The company was founded in 2005 and is based in Saratoga, California. It has a research and development facility in Bangalore, India.

Cellworks Press Mentions

Stay in the know about the latest news on Cellworks

The Best Things Come In Threes

TechCrunch • Sep, 15 2015

Cellworks Management

Leadership team at Cellworks

Co-Founder & Chief Scientific Officer

Shireen Vali

Co-Founder & CEO

Taher Abbasi

Locked Features

Join now and verify your accreditation status to gain access to:

  • Cellworks current valuation
  • Cellworks stock price
  • Available deals in Cellworks and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Cellworks stock?

Accredited investors can buy pre-IPO stock in companies like Cellworks through EquityZen funds. These investments are made available by existing Cellworks shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Cellworks stock?

Shareholders can sell their Cellworks stock through EquityZen's private company marketplace. EquityZen's network includes over 300K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."